Louise J. Riff

1.1k total citations
27 papers, 869 citations indexed

About

Louise J. Riff is a scholar working on Pharmacology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Louise J. Riff has authored 27 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 9 papers in Epidemiology and 8 papers in Infectious Diseases. Recurrent topics in Louise J. Riff's work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Antibiotic Resistance in Bacteria (6 papers). Louise J. Riff is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (17 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Antibiotic Resistance in Bacteria (6 papers). Louise J. Riff collaborates with scholars based in United States and Belgium. Louise J. Riff's co-authors include George Gee Jackson, Robert A. Blum, John C. Rotschafer, Keith A. Rodvold, Kent Crossley, Victoria Schauf, Judith Fischer, Audra Deveikis, Jessica L. Thomason and Marvin Turck and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and The Journal of Immunology.

In The Last Decade

Louise J. Riff

26 papers receiving 734 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Louise J. Riff United States 15 494 273 256 175 135 27 869
C H Nightingale United States 17 657 1.3× 192 0.7× 427 1.7× 325 1.9× 115 0.9× 37 1.0k
G. K. Daikos Greece 16 252 0.5× 140 0.5× 209 0.8× 175 1.0× 70 0.5× 63 648
A. Georgopoulos Austria 17 333 0.7× 157 0.6× 243 0.9× 125 0.7× 99 0.7× 48 883
P. Van der Auwera Belgium 15 260 0.5× 209 0.8× 260 1.0× 151 0.9× 173 1.3× 41 713
Donald L. Bornstein United States 12 187 0.4× 276 1.0× 356 1.4× 254 1.5× 251 1.9× 16 1.3k
Melinda K. Lacy United States 12 537 1.1× 219 0.8× 422 1.6× 316 1.8× 150 1.1× 21 1.0k
Robert Sauermann Austria 19 464 0.9× 283 1.0× 255 1.0× 234 1.3× 168 1.2× 43 1.1k
L Kager Sweden 19 195 0.4× 206 0.8× 173 0.7× 142 0.8× 126 0.9× 53 1.2k
Frédérique Delatour France 9 258 0.5× 411 1.5× 482 1.9× 84 0.5× 105 0.8× 11 1.0k
William K. Lau United States 10 272 0.6× 246 0.9× 250 1.0× 159 0.9× 158 1.2× 12 1.3k

Countries citing papers authored by Louise J. Riff

Since Specialization
Citations

This map shows the geographic impact of Louise J. Riff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise J. Riff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise J. Riff more than expected).

Fields of papers citing papers by Louise J. Riff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise J. Riff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise J. Riff. The network helps show where Louise J. Riff may publish in the future.

Co-authorship network of co-authors of Louise J. Riff

This figure shows the co-authorship network connecting the top 25 collaborators of Louise J. Riff. A scholar is included among the top collaborators of Louise J. Riff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise J. Riff. Louise J. Riff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodvold, Keith A., Robert A. Blum, Louise J. Riff, et al.. (1989). Simulation of Vancomycin Peak and Trough Concentrations Using Five Dosing Methods in 37 Patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 9(1). 10–16. 17 indexed citations
2.
Rodvold, Keith A., Robert A. Blum, Judith Fischer, et al.. (1988). Vancomycin pharmacokinetics in patients with various degrees of renal function. Antimicrobial Agents and Chemotherapy. 32(6). 848–852. 192 indexed citations
3.
Tolpin, Mark D., et al.. (1985). Penicillin Prophylaxis and the Neonatal Microbial Flora. The Journal of Infectious Diseases. 152(5). 1070–1073. 12 indexed citations
4.
Thomason, J L, et al.. (1984). Clinical and Microbiological Characterization of Patients with Nonspecific Vaginosis Associated with Motile, Curved Anaerobic Rods. The Journal of Infectious Diseases. 149(5). 801–809. 50 indexed citations
5.
Schauf, Victoria, et al.. (1983). Chloramphenicol kills Haemophilus influenzae more rapidly than does ampicillin or cefamandole. Antimicrobial Agents and Chemotherapy. 23(3). 364–368. 8 indexed citations
6.
Riff, Louise J. & Jessica L. Thomason. (1982). Comparative aminoglycoside inactivation by .BETA.-lactam antibiotics. Effect of a Cephalosporin and six Penicillins on five aminoglycosides.:EFFECT OF A CEPHALOSPORIN AND SIX PENICILLINS ON FIVE AMINOGLYCOSI DES. The Journal of Antibiotics. 35(7). 850–857. 4 indexed citations
7.
Riff, Louise J., et al.. (1982). Tobramycin and gentamicin are equally safe for neonates: results of a double-blind randomized trial with quantitative assessment of renal function.. PubMed. 2(2). 143–55. 24 indexed citations
8.
Riff, Louise J., et al.. (1982). Use of aminoglycosides in the neonate.. PubMed. 6(2). 155–65. 6 indexed citations
9.
Riff, Louise J.. (1978). Evaluation and Treatment of Urinary Infection. Medical Clinics of North America. 62(6). 1183–1199. 4 indexed citations
10.
Schauf, Victoria, et al.. (1976). Antibiotic-killing kinetics of group B streptococci. The Journal of Pediatrics. 89(2). 194–198. 64 indexed citations
11.
Riff, Louise J.. (1975). Progress in Chemotherapy. Archives of Internal Medicine. 135(10). 1410–1410. 35 indexed citations
12.
Jackson, George Gee, et al.. (1974). Double-Blind Comparison of Cephacetrile with Cephalothin/Cephaloridine. Antimicrobial Agents and Chemotherapy. 5(3). 247–254. 1 indexed citations
13.
Riff, Louise J. & George Gee Jackson. (1972). Laboratory and clinical conditions for gentamicin inactivation by carbenicillin.. PubMed. 130(6). 887–91. 75 indexed citations
14.
Riff, Louise J.. (1972). Chemotherapy in Ear Disease. Otolaryngologic Clinics of North America. 5(1). 3–10. 2 indexed citations
15.
Riff, Louise J. & George Gee Jackson. (1971). Pharmacology of Gentamicin in Man. The Journal of Infectious Diseases. 124(Supplement 1). S98–S105. 143 indexed citations
16.
Riff, Louise J., et al.. (1971). GENTAMICIN PLUS CARBENICILLIN. The Lancet. 297(7699). 592–592. 21 indexed citations
17.
Riff, Louise J., et al.. (1970). Gentamicin Treatment of Serious Gram-Negative Bacillary Infections.. Annals of Internal Medicine. 72(5). 797–797.
18.
Riff, Louise J., et al.. (1969). Therapy with combinations of penicillin analogues in urinary-tract infections.. PubMed. 9. 405–9. 5 indexed citations
19.
20.
Jackson, George Gee, et al.. (1960). SUSCEPTIBILITY AND IMMUNITY TO COMMON UPPER RESPIRATORY VIRAL INFECTIONS—THE COMMON COLD. Annals of Internal Medicine. 53(4). 719–738. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C H Nightingale Breakdown of academic impact, for papers by G. K. Daikos Breakdown of academic impact, for papers by A. Georgopoulos Breakdown of academic impact, for papers by P. Van der Auwera Breakdown of academic impact, for papers by Donald L. Bornstein Breakdown of academic impact, for papers by Melinda K. Lacy Breakdown of academic impact, for papers by Robert Sauermann Breakdown of academic impact, for papers by L Kager Breakdown of academic impact, for papers by Frédérique Delatour Breakdown of academic impact, for papers by William K. Lau
Rankless by CCL
2026